{"id":"NCT00627445","sponsor":"Novo Nordisk A/S","briefTitle":"Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes","officialTitle":"Effect of Biphasic Insulin Aspart 50 Compared to Biphasic Insulin Aspart 30 Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2009-01","completion":"2009-01","firstPosted":"2008-03-03","resultsPosted":"2010-03-31","lastUpdate":"2014-10-22"},"enrollment":441,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"biphasic insulin aspart 30","otherNames":[]},{"type":"DRUG","name":"metformin","otherNames":[]},{"type":"DRUG","name":"biphasic insulin aspart 50","otherNames":[]}],"arms":[{"label":"BIAsp 50-50-30","type":"EXPERIMENTAL"},{"label":"BIAsp 30-30","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Asia. The trial aims to investigate if the blood glucose control of biphasic insulin aspart 50 is at least as effective as treatment with biphasic insulin aspart 30 both in combination with metformin.","primaryOutcome":{"measure":"Change in Glycosylated Haemoglobin A1c (HbA1c)","timeFrame":"week 0, week 16","effectByArm":[{"arm":"BIAsp 50-50-30","deltaMin":-1.79,"sd":0.057},{"arm":"BIAsp 30-30","deltaMin":-1.517,"sd":0.056}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":2},"locations":{"siteCount":1,"countries":["China"]},"refs":{"pmids":[],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":219},"commonTop":["Hyperlipidaemia","Diarrhoea","Upper respiratory tract infection","Nasopharyngitis","Dyslipidaemia"]}}